rokitamycin

10/01/1988 - "[Clinical studies of rokitamycin dry syrup on Chlamydia trachomatis infections in the neonate and infant]."
06/01/1988 - "[Studies on efficacy, safety and dosage of rokitamycin in the treatment of pediatric infections]."
06/01/1988 - "In a study of rokitamycin (RKM) dry syrup for its usefulness in pediatric infections, the following results were obtained: 1. Frequencies of RKM-resistant strains among fresh isolates from sick children were very low, and 4.4% of 68 isolates of Staphylococcus aureus, 4.2% of 48 isolates of Streptococcus pneumoniae, and none of 96 isolates of Streptococcus pyogenes were found to be RKM-resistant. "
05/01/2003 - "Treatment with rokitamycin suppresses the lethality in a murine model of Escherichia coli O157:H7 infection."
01/01/2000 - "[Epidemiological study of Chlamydia trachomatis infection in a sample of women requesting voluntary termination of pregnancy, treated with rokitamycin]."

12/01/1990 - "[Tonsillitis associated with Chlamydia trachomatis and antimicrobial therapy with rokitamycin]."
12/01/1990 - "In this study, we evaluated the efficacy of Rokitamycin, a 16-membered ring macrolide antibiotic agent, in the treatment of tonsillitis associated with C. "
01/01/2010 - "To review current clinical evidence for the use of antibiotics in paediatric upper paediatric respiratory infections, repeated PubMed searches using the template algorithm -rhinosinusitis/otitis/ tonsillitis AND ()- with the settings: -Humans; English; All Child 0-18; Clinical trial; Review; Methanalysis; Guideline; Last 10 years- for the following comparators: antibiotic; amoxicillin; clavulanate; penicillin; cephalosporin; macrolide; erythromycin; rokitamycin; clindamycin; trimethoprim-sulfamethoxazole, cefopodoxime, cefdinir, cefuroxime, ceftriaxone. "

11/01/1998 - "These findings confirm and extend the indications for rokitamycin, found in earlier trials to be extremely effective in the treatment of urethritis due to Chlamydia trachomatis and--as a whole--in infections caused by this microrganism."

09/01/1991 - "The Research Committee for the Effect of Rokitamycin, Research Group for Infectious Enteritis]."
09/01/1991 - "Rokitamycin was considered clinically useful to treat Campylobacter enteritis."
09/01/1991 - "Research Group of Rokitamycin on Infectious Enteritis]."
09/01/1991 - "[A clinical experience of rokitamycin on Campylobacter enteritis. "
02/01/1990 - "[Evaluation of effectiveness of rokitamycin dry syrup in acute enteritis in pediatrics. "

10/01/1988 - "[Clinical studies of rokitamycin dry syrup on skin and soft tissue infections in the pediatric fields]."
03/01/1985 - "[Clinical and bacteriological evaluation of TMS-19-Q in superficial suppurative skin and soft tissue infection]."
10/01/1988 - "Rokitamycin (RKM) dry syrup, a newly developed macrolide antibiotic, was administered to children with ages between 6 months and 15 years and 10 months suffering from skin and soft tissue infections including 41 cases of impetigo, one case of staphylococcal scalded skin syndrome (SSSS) and 2 cases of subcutaneous abscess totalling 44 cases. "